The table below shows IDEAYA Biosciences, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$71.10M
-$247.58M
-$115.22M
-$87.17M
-$55.78M
$55.46M
Capital expenditure
$2.37M
$3.86M
$2.37M
$3.44M
$2.64M
$493.00K
Investing cash flow
$69.98M
-$502.56M
-$158.46M
-$33.40M
-$69.67M
-$146.24M
Dividends paid
-
-
-
-
IDYA operating cash flow (10-K history)
IDEAYA Biosciences, Inc. reported operating cash flow of -$71.10M for fiscal year 2025. That is up 71.3% from -$247.58M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$12.22M (FY 2017) to -$71.10M. Figures come from the company's audited annual reports as filed with the SEC.